Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the gouty arthritis market right now?

In recent times, the gouty arthritis market size experienced robust growth. Its surge from $3.44 billion in 2024 to $3.7 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.6%, pinpoints this growth. Factors such as the rise in chronic diseases, amplified alcohol consumption, an uptick in the aging population, higher acceptance of advanced regeneration therapies, and escalating healthcare costs contribute to the growth seen in the historic period.

How fast Is the gouty arthritis market expected to grow, and what’s its future value?

In the ensuing years, the market size for gouty arthritis is predicted to witness robust growth, anticipating a value of $4.9 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. The projected growth during this period can be credited to the betterment of health care infrastructure, rising obesity levels, an augmented number of gout cases, and enhanced public awareness. Prominent trends over the forecast period encompass the escalating demand for potent treatment alternatives, regenerative healing methods, technological evolution, product introductions, and regulatory green lights.

Get your gouty arthritis market report here!

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

What are the leading drivers of growth in the gouty arthritis market?

The escalating occurrence of obesity is anticipated to fuel the expansion of the gouty arthritis market in the future. Obesity, a health disorder marked by excessive accumulation of body fat to the extent of endangering personal health, is often assessed using the body mass index (BMI). The obesity rate is on the rise, triggered by the amplified intake of high-caloric, processed foods and inactive lifestyles. Obesity heightens gouty arthritis as it causes an increase in uric acid production and hinders the body’s capacity to excrete it, resulting in the build-up of uric acid crystals in the joints. Besides, excessive body weight puts additional strains on the joints, worsening the inflammation and pain linked with gout. For example, as per the World Health Organization, a Switzerland-based specialized United Nations entity responsible for global public health, around 1 billion people made up of 650 million adults, 340 million teenagers, and 39 million children, were regarded as obese as of March 2022, and these numbers continue to escalate. Besides, forecasts suggest that approximately 167 million adults and children will face health risks due to surplus weight by 2025. Hence, the growing occurrence of obesity is fueling the expansion of the gouty arthritis market.

What are the key segments defining the gouty arthritis market?

The gouty arthritis market covered in this report is segmented –

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments

3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

Who are the key players steering the development of the gouty arthritis market?

Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

What are the key trends shaping the future of the gouty arthritis market?

The leading businesses in the gouty arthritis market are intensifying their attempts to create innovative products such as cortrophin gel, in order to deliver more efficient and specific treatment for the disease. Cortrophin gel, otherwise known as repository corticotropin injection, is a refined version of the adrenocorticotropic hormone (ACTH). It is applied for treating diverse inflammatory and autoimmune disorders, including gouty arthritis. For instance, ANI Pharmaceuticals, a pharmaceutical company based in the US, was granted approval from the Food and Drug Administration in October 2023 for a new 1-mL vial size of their Purified Cortrophin Gel. This product is designed for the supplementary treatment of certain patients suffering from acute gouty arthritis flare-ups. At present, Cortrophin Gel is the sole FDA-sanctioned adrenocorticotropic hormone (ACTH) therapy recommended for treating suitable patients with acute gouty arthritis flare situations.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070

Which regions are most influential in expanding the gouty arthritis market?

North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Osteoarthritis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Rheumatoid Arthritis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Arthritis Monoclonal Antibodies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: